Roy Sabo - Publications

Affiliations: 
Biostatistics Virginia Commonwealth University, Richmond, VA, United States 
Area:
Biostatistics Biology

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Simmons GL, Sabo R, Martin E, Brophy D, Radic M, Fisher BJ, Natarajan R, Wijesinghe D, Gol-Chambers A, Hall CE, Aziz M, Hawks KG, Jafri A, Bernard R, Chung HM, et al. Parenteral Ascorbic Acid in Allogeneic HCT Recipients Is Safe and Ameliorates the Cytokine Milieu and Endothelial Injury Following Myeloablative Conditioning Biology of Blood and Marrow Transplantation. 26: S139-S140. DOI: 10.1016/J.Bbmt.2019.12.667  0.316
2020 Fegley AK, Sabo R, Roberts CH, Toor AA, Hawks KG. Favorable Clinical Outcomes with Valacyclovir for Cytomegalovirus Prophylaxis Following Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation. 26: S389. DOI: 10.1016/J.Bbmt.2019.12.314  0.335
2019 Krieger E, Sabo R, Moezzi S, Cain C, Roberts C, Kimball P, Chesney A, McCarty J, Keating A, Romee R, Wiedl C, Qayyum R, Toor A. Killer Immunoglobulin-like Receptor-Ligand Interactions Predict Clinical Outcomes Following Unrelated Donor Transplants. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31676338 DOI: 10.1016/J.Bbmt.2019.10.016  0.329
2019 McKay J, Al-Juhaishi T, Guanhua L, Kmieciak M, Sabo R, Sindel A, Yazbeck V. Rive-CLL: Phase 1 Trial of Rituximab, Idelalisib, and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia Blood. 134: 5482-5482. DOI: 10.1182/Blood-2019-126335  0.311
2019 Al-Juhaishi T, Sabo R, Roberts CH, Hawks KG, Aziz M, Reed JC, Qayyum R, Simmons GL, Clark WB, Chung HM, McCarty JM, Toor AA. Short Course Mycophenolate Mofetil Yields Adequate Immune Reconstitution and Equivalent Alloreactivity Following Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 25: S332. DOI: 10.1016/J.Bbmt.2018.12.536  0.38
2019 Krieger E, Okhomina V, Sabo R, Helou M, Roberts CH, Romee R, McCarty JM, Toor AA, Wiedl CM. 56+ Cell Reconstitution Kinetics in HLA Matched Unrelated Donor Allografts: What Doesn't Kill You Makes You Stronger Biology of Blood and Marrow Transplantation. 25: S324. DOI: 10.1016/J.Bbmt.2018.12.524  0.338
2018 Kobulnicky DJ, Sabo RT, Sharma S, Shubar Ali AS, Kobulnicky KM, Roberts CH, Clark WB, Chung HM, McCarty JM, Toor AA. The influence of lymphoid reconstitution kinetics on clinical outcomes in allogeneic stem cell transplantation. Leukemia & Lymphoma. 1-9. PMID 29616870 DOI: 10.1016/J.Bbmt.2016.12.194  0.339
2018 Maples KT, Sabo RT, McCarty JM, Toor AA, Hawks KG. Maintenance azacitidine after myeloablative allogeneic hematopoietic cell transplantation for myeloid malignancies. Leukemia & Lymphoma. 1-6. PMID 29616863 DOI: 10.1016/J.Bbmt.2017.12.767  0.366
2018 Simmons GL, Ribeiro A, Sabo R, Hawks KG, Aziz M, Wiedl CM, Clark WB, Chung HM, McCarty JM, Roberts CH, Toor AA. Optimization of Anti-Thymocyte Globulin Administration Schedule in Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 24: S333-S334. DOI: 10.1016/J.Bbmt.2017.12.393  0.325
2017 Koparde V, Abdul Razzaq B, Suntum T, Sabo R, Scalora A, Serrano M, Jameson-Lee M, Hall C, Kobulnicky D, Sheth N, Feltz J, Contaifer D, Wijesinghe D, Reed J, Roberts C, et al. Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation. Plos One. 12: e0187771. PMID 29194460 DOI: 10.1371/Journal.Pone.0187771  0.339
2017 Koparde VN, Razzaq BA, Sabo R, Suntum T, Jameson-Lee M, Scalora AF, Hall CE, Serrano MG, Simmons GL, McCarty JM, Clark WB, Reed JC, Chung HM, Kobulnicky DJ, Buck GA, et al. Whole Exome Sequencing to Determine the Likelihood of Graft Versus Host Disease in Stem Cell Transplant Donor-Recipient Pairs Biology of Blood and Marrow Transplantation. 23: 1-3. DOI: 10.1016/J.Bbmt.2016.12.650  0.334
2017 Park Y, Hall CE, Scalora AF, Sabo R, Simmons GL, Manjili M, Clark WB, McCarty JM, Chung HM, Roberts CH, Toor AA. Dynamical System Interactions between T Cells and Monocytes Shape Alloreactivity Following Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 23: S167-S168. DOI: 10.1016/J.Bbmt.2016.12.351  0.329
2017 Leslie K, Rasheed M, Roberts CH, Sabo R, Chung HM, McCarty JM, Yeshcheulova O, Wiedl CM, Clark WB, Simmons GL, Toor AA, Reed JC. Single-Cell Mass Profiling of Reconstituting Donor T Cells Following Stem Cell Transplantation to Predict Alloreactivity Biology of Blood and Marrow Transplantation. 23: S374. DOI: 10.1016/J.Bbmt.2016.12.326  0.34
2016 Haynes ME, Sabo RT, Chaganty NR. Simulating dependent binary variables through multinomial sampling Journal of Statistical Computation and Simulation. 86: 510-523. DOI: 10.1080/00949655.2015.1020313  0.571
2016 Blosser J, Toor AA, Sabo R. Stem Cell Transplantation as a Shattering Event: Meaning Making, Coping and Adjustment Biology of Blood and Marrow Transplantation. 22: S183. DOI: 10.1016/J.Bbmt.2015.11.559  0.336
2016 Hawks K, Held L, Sabo R, McCarty JM, Clark W, Chung H, Toor AA. Enhanced Immunosuppression Free Survival in Matched Related Donor Hematopoietic Cell Transplant Recipients Conditioned with Anti-Thymocyte Globulin Biology of Blood and Marrow Transplantation. 22: S117-S118. DOI: 10.1016/J.Bbmt.2015.11.440  0.346
2015 Toor AA, Sabo R, Salman SR, Moore B, Scalora AF, Aziz M, Kobulnicky J, Meier JA, Shubar Ali AS, Manjili M, Song S, Clark W, McCarty JM, Neale MC, Chung H, et al. Dynamical System Modeling of Immune Reconstitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin Biology of Blood and Marrow Transplantation. 21: S169-S170. DOI: 10.1016/J.Bbmt.2014.11.247  0.325
2012 Portier DA, Sabo RT, Roberts CH, Fletcher DS, Meier J, Clark WB, Neale MC, Manjili MH, McCarty JM, Chung HM, Toor AA. Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients. Bone Marrow Transplantation. 47: 1513-9. PMID 22580767 DOI: 10.1038/Bmt.2012.81  0.365
2011 Toor A, Kmieciak M, Berrie J, Mallory K, Roberts C, Sabo R, Idowu M, Chung H, Veronica B, Clark W, McCarty J, Detwiler M, Kazim L, Manjili M. Distinct Oligoclonal T Cells Are Associated With GVHD or GVHD-Free Responses in Patients With Hematologic Malignancies Following Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 17: S329-S330. DOI: 10.1016/J.Bbmt.2010.12.528  0.359
2011 Portier D, Catherine R, Fletcher D, Sabo R, Rabie S, Clark W, Manjili M, Tessier J, Chung H, McCarty J, Toor A. Use of Rabbit Anti-Thymocyte Globulin for Conditioning in Matched Unrelated Donor Hematopoietic Cell Transplantation Provides Comparable Dose Dependant Outcomes to Matched Related Donor Recipients Biology of Blood and Marrow Transplantation. 17: S303. DOI: 10.1016/J.Bbmt.2010.12.448  0.356
Show low-probability matches.